Patients Stopping Anti-Obesity Jabs Regain Weight at a Quadrupled Rate Compared to Dieters

New research indicates that patients who stop using new weight-loss injections like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who stop conventional diet and exercise regimens.

Published data in a major medical journal shows that while obese people can lose a large proportion of their body weight while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals buying these medications need to be aware of the danger of rapid weight regain when the therapy concludes," warns lead investigator Dr. Susan Jebb.

That rate of recovery suggests a reversion to original weight within about a year and a half.

Comparing Approaches

The analysis, which looked at dozens of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with other pills.

The team emphasize that individuals who shed pounds through lifestyle changes alone generally experience a slower weight regain—around 0.1 kg a month—post-intervention.

Understanding the Fast Regain

Nutrition scientists believe the mode of action of the jabs is key to understanding the amplified weight return.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of the hormone levels several times higher than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement results in appetite is unsuppressed, making excessive eating far more likely."

An Ongoing Disease?

Health authorities suggest the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.

Many experts argue that, due to the high risk of weight regain, the therapy should be considered life-long.

This perspective is echoed by pharmaceutical companies, who note that the findings "emphasize the chronic character of excess weight," comparing it to managing conditions like diabetes.

Patient Testimonies

Users who have come off the medication report a intense return of hunger.

"It was like a trigger flipping and you become ravenous," said an individual.

The struggle is exacerbated if users have not developed permanent lifestyle or habit changes during therapy.

Growing Use

Figures suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.

• Use is higher among women compared to males.
• The middle-aged demographic shows the highest usage rates.
• Many obtain the drugs through private prescriptions rather than the NHS.

Ultimately, clinicians stress that while these medications are powerful agents for weight loss, they are not a magic cure and maintained weight loss hinges on ongoing lifestyle changes.